Researchers Urge Second COVID Vaccine Dose for Infliximab Users Researchers Urge Second COVID Vaccine Dose for Infliximab Users

Patients being treated with infliximab had weakened immune responses to the first dose of the Pfizer and AstraZeneca COVID vaccines compared with patients on vedolizumab, according to a new UK study.Medscape Medical News
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news